Case Studies/Wholesale/SHREEK MEDS LIMITED
Creditors' voluntary liquidation

SHREEK MEDS LIMITED

SHREEK MEDS LIMITED is tracked from The Gazette and Companies House public record. Creditors' voluntary liquidation proceedings were first recorded on 9 March 2026.

Key facts
Company no.11275363
SectorWholesale
Incorporated26 Mar 2018
Reg. officeNorthampton NN1
Appointed9 Mar 2026
Office holderDean Andrew Smith, Revolutionrti
The timeline · incorporation → liquidation
26 Mar 2018
Incorporated
Registered as 11275363. Wholesale.
24 Dec 2019
First accounts filed
accounts-with-accounts-type-micro-entity
31 Mar 2025
Latest accounts filed
accounts-with-accounts-type-micro-entity
9 Mar 2026
Liquidator appointed
Creditors' voluntary liquidation.
9 Mar 2026
Gazette notice published
Notice 5074120 in The Gazette.

What the data was telling us

Readings from The Gazette and Companies House, in the firm's final two years.

Insolvency statusCVL
StatusCreditors' voluntary liquidation
Gazette refNotice 5074120
EditionThe Gazette
Appointed byMembers & creditors
UnderInsolvency Act 1986, s.100 & s.109
Ownership & controlPSC register
Beneficial ownerMr Sanket Mukundbhai Shah
ControlSignificant influence or control
Owner typeIndividual
Controllers1 on record
Filing trajectoryLate filing
Incorporated26 Mar 2018
Last accounts31 Mar 2025
Confirmation stmtFiled
Account typeMicro-entity
Director stabilityBoard churn
Appointments1 since 2018
Resignations0 in final 12 mths
Active directors1
Avg tenure8.0 yrs
Director track recordTrack record
Other appointments2 other companies
DisqualificationsNone found
Practitioner appointedPractitioner
PractitionerDean Andrew Smith
FirmRevolutionrti
RoleLiquidator
IP numberIP 9596
AppointedUnknown
View profile →
The full forensic report

Every charge, every filing, every appointment, in one dossier.

Director histories across related entities, the full debenture instrument, creditor estimates, and the practitioner's record on comparable cases for SHREEK MEDS LIMITED.